• Darren Campili will be based at the bank's London office
  • Deutsche Bank hires Jamie Heath as managing director in London

Deutsche Bank AG named Darren Campili as global co-head of health-care investment banking coverage, according to a spokeswoman for the bank.

Campili, who had been head of health-care investment banking for Europe, the Middle East and Africa for six years, will continue to be based in London and report to Alasdair Warren, who leads corporate and investment banking in EMEA, the spokeswoman said.

In his previous role, Campili worked on some of the largest deals in the industry, including Shire Plc’s $32 billion acquisition of Baxalta Inc. and the company’s purchase of Dyax Corp. last year. He also advised Takeda Pharmaceutical Co. on its purchase of Swiss drugmaker Nycomed in 2011 for 9.6 billion euros ($10.9 billion) in cash and debt.

He will share leadership of the team with Michael Cohen, based in New York. Prior to joining Deutsche Bank, Campili was head of business development at pharmaceutical company Novartis AG and its generics division Sandoz.

Deutsche Bank is also boosting coverage of health-care deals, appointing Jamie Heath as managing director in London. Heath will join Deutsche Bank in June from consultancy firm EY, where he ran transaction advisory for life sciences companies. Prior to EY, Heath worked at Centerview Partners and Bank of America Corp.’s Merrill Lynch.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE